It is time to reconsider leukoreduction of whole blood for use in patients with life-threatening hemorrhage.

IF 2.5 3区医学 Q2 HEMATOLOGY

Transfusion Pub Date : 2024-10-17 DOI:10.1111/trf.18047

Mark H Yazer, Andrew Beckett, Evan M Bloch, Andrew P Cap, Claudia S Cohn, Jennifer Gurney, Daniela Hermelin, Philip C Spinella

引用次数: 0

查看原文本刊更多论文

现在是时候重新考虑将全血减白用于危及生命的大出血患者了。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Transfusion 医学-血液学

CiteScore

4.70

自引率

20.70%

发文量

426

审稿时长

1 months

期刊介绍： TRANSFUSION is the foremost publication in the world for new information regarding transfusion medicine. Written by and for members of AABB and other health-care workers, TRANSFUSION reports on the latest technical advances, discusses opposing viewpoints regarding controversial issues, and presents key conference proceedings. In addition to blood banking and transfusion medicine topics, TRANSFUSION presents submissions concerning patient blood management, tissue transplantation and hematopoietic, cellular, and gene therapies.